OGGQX
Price
$9.81
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
UGSCX
Price
$12.25
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
Ad is loading...

OGGQX vs UGSCX

Header iconOGGQX vs UGSCX Comparison
Open Charts OGGQX vs UGSCXBanner chart's image
JPMorgan Government Bond R4
Price$9.81
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
American Funds US Government Sec C
Price$12.25
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
OGGQX vs UGSCX Comparison Chart
Loading...
VS
OGGQX vs. UGSCX commentary
Sep 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OGGQX is a Hold and UGSCX is a Hold.

FUNDAMENTALS
Fundamentals
UGSCX has more cash in the bank: 18.3B vs. OGGQX (2.01B). UGSCX pays higher dividends than OGGQX: UGSCX (3.19) vs OGGQX (2.56). OGGQX was incepted earlier than UGSCX: OGGQX (8 years) vs UGSCX (24 years). UGSCX is a more actively managed with annual turnover of: 795.00 vs. OGGQX (14.00). OGGQX has a lower initial minimum investment than UGSCX: OGGQX (0) vs UGSCX (250). OGGQX annual gain was more profitable for investors over the last year : 9.76 vs. UGSCX (8.70). OGGQX return over 5 years is better than : 0.09 vs. UGSCX (-4.61).
OGGQXUGSCXOGGQX / UGSCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years24 years-
Gain YTD5.0283.670137%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.01B18.3B11%
Annual Yield % from dividends2.563.1980%
Returns for 1 year9.768.70112%
Returns for 3 years-4.61-7.0665%
Returns for 5 years0.09-4.61-2%
Returns for 10 yearsN/A-0.90-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MTEM1.360.05
+3.82%
Molecular Templates
ABM50.94-0.02
-0.04%
ABM Industries
AGR35.73-0.04
-0.11%
Avangrid
OFLX51.14-0.14
-0.27%
Omega Flex
TNYA2.02-0.05
-2.42%
Tenaya Therapeutics